Literature DB >> 17392170

The toxicity of the PrP106-126 prion peptide on cultured photoreceptors correlates with the prion protein distribution in the mammalian and human retina.

Jie Gong1, Abdeljelil Jellali, Valérie Forster, Jérôme Mutterer, Elisabeth Dubus, Wilko D Altrock, José A Sahel, Alvaro Rendon, Serge Picaud.   

Abstract

In patients affected by Creutzfeldt-Jakob disease and in animals affected by transmissible spongiform encephalopathies, retinal functions are altered, and major spongiform changes are observed in the outer plexiform layer where photoreceptors have their synaptic terminals. In the present study, the prion protein PrP(c) was found to form aggregates in rod photoreceptor terminals from both rat and human retina, whereas no labeling was observed in cone photoreceptors. Discrete staining was also detected in the inner plexiform layer where the prion protein was located at human amacrine cell synapses. In mixed porcine retinal cell cultures, the PrP106-126 prion peptide triggered a 61% rod photoreceptor cell loss by apoptosis as indicated by terminal deoxynucleotidyl transferase dUTP nick-end labeling, whereas cone photoreceptors were not affected. Amacrine cells were also reduced by 47% in contrast to ganglion cells. Although this cell loss was associated with a 5.5-fold increase in microglial cells, the strict correlation between the PrP(c) prion protein expression and the peptide toxicity suggested that this toxicity did not rely on the release of a toxic compound by glial cells. These results provide new insights into the retinal pathophysiology of prion diseases and illustrate advantages of adult retinal cell cultures to investigate prion pathogenic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392170      PMCID: PMC1829464          DOI: 10.2353/ajpath.2007.060340

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Differential expression of the presynaptic cytomatrix protein bassoon among ribbon synapses in the mammalian retina.

Authors:  J H Brandstätter; E L Fletcher; C C Garner; E D Gundelfinger; H Wässle
Journal:  Eur J Neurosci       Date:  1999-10       Impact factor: 3.386

2.  Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.

Authors:  A R White; R Guirguis; M W Brazier; M F Jobling; A F Hill; K Beyreuther; C J Barrow; C L Masters; S J Collins; R Cappai
Journal:  Neurobiol Dis       Date:  2001-04       Impact factor: 5.996

3.  Abnormal prion protein in the retina of the most commonly occurring subtype of sporadic Creutzfeldt-Jakob disease.

Authors:  M W Head; A H Peden; H M Yull; D L Ritchie; R E Bonshek; A B Tullo; J W Ironside
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

4.  Selective loss of the electroretinogram B-wave in a patient with Creutzfeldt-Jakob disease.

Authors:  B J Katz; J E Warner; K B Digre; D J Creel
Journal:  J Neuroophthalmol       Date:  2000-06       Impact factor: 3.042

5.  Creutzfeldt-Jakob disease and optic atrophy.

Authors:  R L Lesser; D M Albert; A R Bobowick; F H O'Brien
Journal:  Am J Ophthalmol       Date:  1979-03       Impact factor: 5.258

6.  In vivo cytotoxicity of the prion protein fragment 106-126.

Authors:  M Ettaiche; R Pichot; J P Vincent; J Chabry
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

7.  The role of prion peptide structure and aggregation in toxicity and membrane binding.

Authors:  D L Rymer; T A Good
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

8.  In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.

Authors:  Joëlle Chabry; Christiane Ratsimanohatra; Isabelle Sponne; Pierre-Paul Elena; Jean-Pierre Vincent; Thierry Pillot
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

9.  Neurons and astrocytes respond to prion infection by inducing microglia recruitment.

Authors:  Mathieu Marella; Joëlle Chabry
Journal:  J Neurosci       Date:  2004-01-21       Impact factor: 6.167

10.  Prion protein accumulation in eyes of patients with sporadic and variant Creutzfeldt-Jakob disease.

Authors:  Mark W Head; Victoria Northcott; Kathleen Rennison; Diane Ritchie; Linda McCardle; Tristan J R Bunn; Neil F McLennan; James W Ironside; Andrew B Tullo; Richard E Bonshek
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-01       Impact factor: 4.799

View more
  4 in total

1.  Copper-induced structural conversion templates prion protein oligomerization and neurotoxicity.

Authors:  Chi-Fu Yen; Dilshan S Harischandra; Anumantha Kanthasamy; Sanjeevi Sivasankar
Journal:  Sci Adv       Date:  2016-07-01       Impact factor: 14.136

2.  EGCG-mediated autophagy flux has a neuroprotection effect via a class III histone deacetylase in primary neuron cells.

Authors:  Ju-Hee Lee; Ji-Hong Moon; Sung-Wook Kim; Jae-Kyo Jeong; Uddin Md Nazim; You-Jin Lee; Jae-Won Seol; Sang-Youel Park
Journal:  Oncotarget       Date:  2015

3.  Prion-induced photoreceptor degeneration begins with misfolded prion protein accumulation in cones at two distinct sites: cilia and ribbon synapses.

Authors:  James F Striebel; Brent Race; Jacqueline M Leung; Cindi Schwartz; Bruce Chesebro
Journal:  Acta Neuropathol Commun       Date:  2021-01-29       Impact factor: 7.801

4.  Prion Seeds Distribute throughout the Eyes of Sporadic Creutzfeldt-Jakob Disease Patients.

Authors:  Christina D Orrù; Katrin Soldau; Christian Cordano; Jorge Llibre-Guerra; Ari J Green; Henry Sanchez; Bradley R Groveman; Steven D Edland; Jiri G Safar; Jonathan H Lin; Byron Caughey; Michael D Geschwind; Christina J Sigurdson
Journal:  mBio       Date:  2018-11-20       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.